SCRIPPS RESEARCH INSTITUTE, THE
Managing Alpha-1-Antitrypsin Deficiency (AATD) through Proteostasis Signaling Pathways
Managing Alpha-1-Antitrypsin Deficiency (AATD) through Proteostasis Signaling Pathways is a funding opportunity from SCRIPPS RESEARCH INSTITUTE, THE, up to 855694, closing February 29, 2028.
Feb 29, 2028
(578d left)Overview
Project Summary/Abstract: Alpha-1-antitrypsin (AAT) deficiency (AATD) is the most common, underdiagnosed inherited genetic condition (1:1500) and the primary modifier for chronic obstructive pulmonary disease (COPD) (300 million patients world- wide- 3 million deaths annually). AATD is an aging and genotype sensitive…